Trial intelligence / Profile preview

Shuhe Granules for chronic insomnia

ChiCTR2200063741Phase 2Not yet recruiting

Sponsor
Guangdong Provincial Hospital of Traditional Chinese Medicine
Start
Jun 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of Shuhe granule in Insomnia (2 arms), sponsored by Guangdong Provincial Hospital of Traditional Chinese Medicine. Primary endpoint: Insomnia Severity Index total score. Planned start Jun 2022; status: not yet recruiting.

02

Drugs

Shuhe granule
03

Conditions

Insomnia

Beyond the preview

Go deeper on ChiCTR2200063741.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2200063741.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call